Association between Polycystic Ovary Syndrome and Gut Microbiota
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Polycystic ovary syndrome (PCOS) is the most frequent endocrinopathy in women of reproductive age. It is difficult to treat PCOS because of its complex etiology and pathogenesis. Here, we characterized the roles of gut microbiota on the pathogenesis and treatments in letrozole (a nonsteroidal aromatase inhibitor) induced PCOS rat model. Changes in estrous cycles, hormonal levels, ovarian morphology and gut microbiota by PCR-DGGE and real-time PCR were determined. The results showed that PCOS rats displayed abnormal estrous cycles with increasing androgen biosynthesis and exhibited multiple large cysts with diminished granulosa layers in ovarian tissues. Meanwhile, the composition of gut microbiota in letrozole-treated rats was different from that in the controls. Lactobacillus, Ruminococcus and Clostridium were lower while Prevotella was higher in PCOS rats when compared with control rats. After treating PCOS rats with Lactobacillus and fecal microbiota transplantation (FMT) from healthy rats, it was found that the estrous cycles were improved in all 8 rats in FMT group, and in 6 of the 8 rats in Lactobacillus transplantation group with decreasing androgen biosynthesis. Their ovarian morphologies normalized. The composition of gut microbiota restored in both FMT and Lactobacillus treated groups with increasing of Lactobacillus and Clostridium, and decreasing of Prevotella. These results indicated that dysbiosis of gut microbiota was associated with the pathogenesis of PCOS. Microbiota interventions through FMT and Lactobacillus transplantation were beneficial for the treatments of PCOS rats.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In particular, mice models have shown a correlation between the microbiota and hyperandrogenaemia in mice with polycystic ovary syndrome (PCOS).(11-13)t”
From Association Between Sex Hormone Levels and Gut Microbiota Composition and Diversity—A Systematic Review (2022) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Vrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R. S., Bartelsman, J. F. W. M., Dallinga–Thie, G. M., Ackermans, M. T., Serlie, M. J., Oozeer, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.031 · Cited by 2,913 · cited 1×
“Patients with metabolic syndrome increased insulin sensitivity after infusion of microbiota from lean donors [24].”
BackgroundSex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity
Markle, J. G. M., Frank, D. N., Mortin-Toth, S., Robertson, C. E., Feazel, L. M., Rolle-Kampczyk, U., von Bergen, M., McCoy, K. D., Macpherson, A. J., & Danska, J. S. (2013) · Science · doi:10.1126/science.1233521 · Cited by 2,025 · cited 2×
“Transplantation of the male microbiome to immature females increased the level of testosterone and formed a testosterone-dependent metabolite profile in the female recipients and robust T1D protection [18].”
BackgroundClarke, G., Grenham, S., Scully, P., Fitzgerald, P., Moloney, R. D., Shanahan, F., Dinan, T. G., & Cryan, J. F. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.77 · Cited by 1,893
Ehrmann, D. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041536 · Cited by 1,881
Intestinal homeostasis and its breakdown in inflammatory bowel disease
Maloy, K. J., & Powrie, F. (2011) · Nature · doi:10.1038/nature10208 · Cited by 1,870
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.217 · Cited by 1,488
Norman, R. J., Dewailly, D., Legro, R. S., & Hickey, T. E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61345-2 · Cited by 1,360
Dysbiosis of the faecal microbiota in patients with Crohn’s disease and their unaffected relatives
Joossens, M., Huys, G., Cnockaert, M., De Preter, V., Verbeke, K., Rutgeerts, P., Vandamme, P., & Vermeire, S. (2011) · Gut · doi:10.1136/gut.2010.223263 · Cited by 1,063
(2016) · Dietetic and Nutrition Case Studies · doi:10.1002/9781119163411.ch73 · Cited by 1,013
Research works printed but not linked: 1
- Markle JG, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, Rolle-Kampczyk U, et al. Sex differ- ences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science. 2013; 339 (6123):1084-8. doi: 10.1126/science.1233521 PMID: 23328391. · DOI · Paper page
Cited by
Items 301–349 of 349
Rare and Underappreciated Causes of Polycystic Ovarian Syndrome
Sacerdote, A. S. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.101946 · Cited by 2
“Although there are no human studies to date, a small study assessing fecal transplant to treat PCOS in a rodent model has been reported with encouraging results [48].”
ResultEndometrial Cancer and Precancer in Polycystic Ovary Syndrome
Marcus, E. A., Haines, K. E., & Gressel, G. M. (2022) · Springer eBooks · doi:10.1007/978-3-030-92589-5_21
Zheng, Y., Ma, H., Xu, Y., Liang, C., & Yang, T. (2020) · Research Square · doi:10.21203/rs.3.rs-97809/v1
“It is universally acknowledged that PCOS is a kind of complex heterogeneous disease [28,29], altered gut microbiome may be associated with the occurrence of PCOS [30].”
BackgroundDevelopmental origins and genetic basis of polycystic ovary syndrome
Barber, T., & Franks, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91380-5.00009-5 · Cited by 1
A Tour-d’Horizon of microbiota therapeutics for metabolic disorders
Saifi, S., Swaminathan, A., Devi, P., Chattopadhyay, P., Gupta, S., Garg, A., Saxena, S., Parveen, S., & Pandey, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99336-4.00006-9
Islam, R., & Saha, T. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815123975123010004
An Intricate relationship between Microbes and Metabolites leads of Novel PCOS BiomarkersPreprint
Niranjan, V., Eshwar, S., Pooja, S., Uttarkar, A., & Likitha, S. (2023) · Research Square · doi:10.21203/rs.3.rs-3281208/v1
Perspectives of PCOS Pathophysiology: Exploring the Interplay between PCOS and the Gut Microbiota
Khade, K., Dadachanji, R., & Mukherjee, S. (2023) · Journal of Endocrinology & Reproduction · doi:10.18311/jer/2023/34986
Zhao, Y., Ma, X.-M., Ren, M., Liu, H., Duan, H.-L., Liu, X., Gao, Z.-S., & Ma, Y. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22742
“Increased level of Prevotella is associated with an inflammatory response in polycystic ovary syndrome rats and leads to hyperandrogenism [47].”
BackgroundA review on polyherbal and supplemental approach to treat Polycystic Ovarian Syndrome
Priya, & Rana, S. (2023) · Research in Pharmacy · doi:10.25081/rip.2023.v13.8683 · Cited by 3
Features of the Gut Microbiota in Patients with Polycystic Ovary Syndrome
Дмитриевна, К. Е., Muravieva, V. V., Леонидовна, И. Е., Skorobogatiy, A. V., Zhigalova, K. N., Kozlova, A. A., Priputnevich, T. V., & Евгеньевна, Ч. Г. (2023) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn6442 · Cited by 1
Chestnut polysaccharides rescue impaired spermatogenesis by adjusting gut microbiotaPreprint
Sun, Z., Yu, S., Tian, Y., Han, B., Zhao, Y. M., Li, Y., Wang, Y., Sun, Y., & Shen, W. (2024) · doi:10.22541/au.170668093.35367017/v1
Introduction to gut microbiome and epigenetics
Oshinjo, A. M., Michael, O. S., Adedayo, L. D., Adetunji, C. O., Bamidele, O., Adetunji, J. B., Morakinyo, A., Akinwale, E. O., Ajayi, O. O., Awobajo, F. O., et al. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91190-0.00009-6
Role of Gut Microbiota in Polycystic Ovary Syndrome
Dhiman, S., Gupta, A. A., & Garg, R. (2024) · Journal of South Asian Federation of Obstetrics and Gynaecology · doi:10.5005/jp-journals-10006-2466
王, 钰. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1482299
Sajjad, J., Morael, J., Melo, T. G., Foley, T., Murphy, A., Keane, J., Popov, J., Stanton, C., Dinan, T. G., Clarke, G. A., et al. (2024) · Neuroscience Letters · doi:10.1016/j.neulet.2024.138096
Gestörte Metabolik und kardiovaskuläres Risiko am Beispiel des polyzystischen Ovarialsyndroms (PCOS)
Arjune, S., & Hanßen, R. (2025) · Aktuelle Kardiologie · doi:10.1055/a-2606-7002
Exploring the interactions of gut microbiome and metabolites in polycystic ovary syndrome: a review
Li, J., Jia, Y., Xu, H., Bing, H., Ling, Q., Wang, S., Wang, Y., Zhang, X., & Zhao, L. (2025) · Microbiological Research · doi:10.1016/j.micres.2025.128309 · Cited by 1
Self-citationTalebi, S., Shab-Bidar, S., Mohammadi, H., Moini, A., & Djafarian, K. (2024) · Figshare · doi:10.6084/m9.figshare.26632147
Mayneris‐Perxachs, J., Arnoriaga‐Rodríguez, M., Luque-Córdoba, D., Priego‐Capote, F., Pérez-Brocal, V., Moya, A., Burokas, A., Maldonado, R. J., & Fernández-Real, J.-M. (2020) · Figshare · doi:10.6084/m9.figshare.12981212
Mayneris‐Perxachs, J., Arnoriaga‐Rodríguez, M., Luque-Córdoba, D., Priego‐Capote, F., Pérez-Brocal, V., Moya, A., Burokas, A., Maldonado, R. J., & Fernández-Real, J.-M. (2020) · Figshare · doi:10.6084/m9.figshare.12981224
Gut and Vaginal Microbiome Dysbiosis in PCOS
Kottahachchi, D., Subasinghe, C., & Bajaj, S. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898810931125010021
Maternal Microbiota and Its Potential Implications for Mammalian Reproduction Health
Lei, X., Zheng, Y., Chen, Y., Jiang, J., CHEN, G., & Ye, Q. (2026) · Journal of Nutrition · doi:10.1016/j.tjnut.2026.101366 · Cited by 1
Ye, J., Cen, S., Qi, Q., Wang, C., Wang, J., Wang, J., Yaping, G., & Wang, J. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-025-02158-x
“The pathogenesis of PCOS remains unclear [6], but studies have linked it to genetic, environmental, and psychological factors [7].”
Shirani, M., Bagherniya, M., Sadeghi, O., Tehrani, H. G., Eskandari, M. H., Sharma, M., & Askari, G. (2026) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.18502/ijrm.v23i11.20547
“Probiotics can maintain the integrity of the intestinal barrier through the production of short-chain fatty acids, which are related to a reduction in insulin resistance and inflammation (28).”
Wu, Q., Wang, M., Yang, J., Wang, J., Feng, S., Lu, S., Qin, Z., He, X., & Wu, L. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1715020
“The abundance of Lactobacillus , Ruminococcus and Fusobacterium in letrozole-induced Polycystic Ovary Syndrome (PCOS) rats was lower, while the abundance of Prevotella was higher than that in the control rats (38).”
InfluentialWang, Y., Zhang, C.-J., Yang, J., Wang, Y.-H., Kang, A.-H., Liu, X.-T., Liu, Y., Cai, Q.-Q., Li, X., Zhang, F.-F., et al. (2026) · Reproductive and Developmental Medicine · doi:10.1097/rd9.0000000000000162
Self-citationLi, T., Kuang, H., Zhang, J., Meng, Y., Feng, X., Mao, X., Pan, Z., & Sun, M. (2026) · Current Microbiology · doi:10.1007/s00284-026-04918-x · Cited by 1
“…tract (such as permeability and blood supply), and ↓ Ruminococcus [13] , ↓ Lactobacillus [13] , ↓ Bifido - bacterium [15] , ↓ Akkermansia [14] ; ↑ Actinobacteria [9] ↑ Prevotella [12, 13] ↓ Bifidobacterium [18] , ↓ Lachnospira-ceae [18] ; ↑ Shigella/Escherichia [17] , ↑ Actinobacteria…”
Metabolic aspects of polycystic ovary syndrome
Pappas, D., Kandaraki, E., Kalogirou, A., & Diamanti‐Kandarakis, E. (2026) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2026.2656240
“Likewise, fecal microbiota transplantation (FMT) in preclinical models has demonstrated reversal of PCOS-like reproductive and metabolic disturbances, further establishing the gut microbiome as a potential therapeutic target [77].”
Li, Y. Y., He, F.-F., Donge‐Liu, Bin‐Xu, & Shuyi‐Li (2026) · Health Science Reports · doi:10.1002/hsr2.72593
“Furthermore, individuals with PCOS face an increased susceptibility to metabolic disturbances such as insulin resistance (IR), abnormal lipid levels, obesity, type 2 diabetes, and cardiovascular complications [4–6].”
Li, T., Chen, H., Liu, J., Lu, H., Lu, T., Reyimu, R., Wang, X., Zhang, J., Li, S., Liu, X., et al. (2026) · Frontiers in Veterinary Science · doi:10.3389/fvets.2026.1823444
“Wang et al. (52) analyzed the gut microbiota of letrozole-induced polycystic ovary syndrome (PCOS) model rats and found an insufficient abundance of bacteria from the genus Ruminococcus .”
InfluentialHormonal Imbalance and Gut Dysbiosis: Emerging Perspectives in Women’s Health
De, R., Chakrabortty, S., Das, J., Chaudhary, P., Patra, R., Sardar, K., Nath, R., Pal, R., Debnath, B., & Ashique, S. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11089-5 · Cited by 1
Tunjungseto, A., Hadi, O. A., Pratiwi, I. W., Iffatunnisa, F., Ahsan, F., & Santoso, B. (2026) · Diagnostics · doi:10.3390/diagnostics16132041
The gut microbiome as a therapeutic potential for inborn errors of metabolism disorders
Parihar, S., Kumar, L., Dube, S., & Mohanty, S. S. (2026) · Discover Medicine · doi:10.1007/s44337-026-00640-6
“This dysbiosis is characterised by plenty of microorganisms related to steroid hormone synthesis, Clostridiaceae and Nocardiaceae, and a lower abundance of beneficial bacteria such as Akkermansia, Bacteroides, Lactobacillus, and Clostridium [57, 58].”
Therapeutic potential of natural products in polycystic ovary syndrome
Bai, C., & Liu, J. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12324-6
“Thus, modulating gut microbiota can help alleviate PCOS symptoms [99].”
Jin, S., Zhu, M., Lu, Y., Zhao, J., Zhu, J., & Fang, X. (2026) · Experimental Biology and Medicine · doi:10.3389/ebm.2026.11058
“Another study conducted in letrozole-induced PMOS rats enhanced estrous cyclicity, decreased serum androgen concentrations, reinstated normal ovarian morphological structure, and normalized the composition of gut microbiota [85].”
Świderska, M., Papińska, J., Buziak, J., Lengier, M., Małyszek, P., Pastuszak, F. C., Świstak, S., Powęska, N., Zych, S., & Pielacha, J. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(51).2026.6234
Liu, F.-T., Yang, Z., Song, Y., Fan, J.-H., Zhou, P., Yu, Y., Yang, S., & Li, R. (2026) · European journal of medical research · doi:10.1186/s40001-026-04923-7
“Notably, this dysbiosis can be improved through fecal microbiota transplantation from healthy donors [17].”
Gut microbiota and polycystic ovary syndrome: Pathogenesis and novel therapeutic approaches
Zhu, T., Sha, Y., Wang, Q., Yang, H., & Liu, T. (2026) · Microbiological Research · doi:10.1016/j.micres.2026.128643
Síndrome dos ovários policísticos e sua relação com a microbiota intestinal
Righi, G. M., de Oliveira, T. F., & Baracat, M. C. P. (2021) · Femina · doi:10.61622/0100-72544910202108 · Cited by 12
The Female Reproductive Microbiome: Mechanistic Insights and Bioengineering Perspectives
Díaz, M. B. N., Carriere, P., Vinderola, G., Gentili, C., & Cattoni, D. I. (2026) · Biology · doi:10.3390/biology15161337
“Preclinical studies have shown that fecal microbiota transplantation may improve hormonal metabolism in PMOS [152,153] and attenuate endometriotic lesion development [154].”
Elhennawy, F., Naji, B., & Butler, A. E. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1900535
Yang, Y., Dai, F., He, X., Zhao, P., & Chen, Q. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1945464
“Evidence from animal studies shows that in rat models of PCOS, interventions involving healthy FMT or exogenous Lactobacillus administration not only restore disrupted gut microecology but also alleviate estrous cycle irregularities and ovarian polycystic-like changes (84).”
Gao, Y., Fan, L., Ma, R., & Wu, L. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1886749 · Cited by 1
“Another study demonstrated that both FMT and Lactobacillus supplementation improve PCOS-like reproductive – endocrine and metabolic abnormalities via gut microbiota modulation (61).”
Kusamoto, A., Osuga, Y., Hirota, Y., & Harada, M. (2026) · Reproductive Medicine and Biology · doi:10.1002/rmb2.70097
“Experimental evidence from letrozole-induced PMOS rodent models demonstrated that gut microbiota composition differed between PMOS models and healthy controls [80, 81].”
Nevins, A., Stansbury, N. M., Robinson, R. D., & Zhong, G. (2026) · Pathogens · doi:10.3390/pathogens15101003
“Healthy-donor fecal transfer or Lactobacillus administration improved reproductive and metabolic features in a rat PCOS model [54].”
Naveed, M., Yang, T., Togliatti, O., Joe, B., & Hill, J. W. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-026-10085-y
Prasad, A., Kishan, A., & Keezhadath, S. (2026) · Metabolites · doi:10.3390/metabo16100758
“At the functional level, gut-derived metabolites such as short-chain fatty acids and indole-3-propionic acid are altered in women with PCOS and are associated with dietary intake [42].”
Metadata
- Authors
- Guo, Y., Qi, Y., Yang, X., Zhao, L., Wen, S., Liu, Y., & Tang, L.
- Affiliations
- Dalian Medical University (CN)
- Corresponding author
- Tang, Li
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-04-19
- Volume
- 11
- Issue
- 4
- Pages
- e0153196
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4836746
- OpenAlex
- W2339818293
- Cited by
- 350
- References
- 46
- Citations by year
- 2026: 40 · 2025: 36 · 2024: 50 · 2023: 44 · 2022: 54 · 2021: 38 · 2020: 42 · 2019: 17 · 2018: 20 · 2017: 6 · 2016: 2
- FWCI
- 19.95
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- This study was supported by grants from the National Program on Key Basic Research Project (973 Program) (NO. 2013CB531405)
- the National Program on Key Basic Research Project (863 Program) (NO. 2014AA022200)
- the National Natural Science Foundation of China (No. 81370113)
- Fund form education Department of Liaoning Province (NO.L2015143)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Keywords
- polycystic ovary syndrome, gut microbiota, dysbiosis, letrozole-induced PCOS, fecal microbiota transplantation, Lactobacillus, Prevotella, Clostridium, Ruminococcus, androgen production, estrous cycle, ovarian morphology, PCOS rat model
- MeSH terms
- Gastrointestinal Microbiome, Letrozole, Animals, Female, Nitriles, Ovary, Polycystic Ovary Syndrome, Triazoles, Rats, Sprague-Dawley, Estrous Cycle, Aromatase Inhibitors, Rats, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.